This content was funded by Sandoz.
This infographic highlights the undertreatment of bone health in osteoporosis and metastatic bone disease, and explores the current treatment options available, with a focus on recent approvals of denosumab biosimilars.
Rate this content's potential impact on patient outcomes
Thank you!
Please share some more information on the rating you have given